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Study Objectives: To evaluate the association between sleep duration and neurocognitive function in a representative sample of middle-aged to older 
Hispanic/Latino adults in the US. We tested the hypothesis that sleep duration has a nonlinear, inverted U-shaped association with neurocognitive function.
Methods: We performed a cross-sectional analysis from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) participants ages 45–74 years 
(n = 8,676). HCHS/SOL is a community-based cohort from four US urban areas sampled using a probability design from 2008–2011. Self-reported sleep 
duration was calculated as a weighted average of the difference between habitual wake and bedtimes assessed by separate questions for weekdays and 
weekends. Neurocognitive function was measured with standardized scores for Word (Phonemic) Fluency (WF), Brief-Spanish English Verbal learning test 
(B-SEVLT), and Digit Symbol Substitution (DSS) tests.
Results: The mean age was 56.5 years; 55% were women; and 40.4% had less than high school education. Average sleep duration was 7.8 ± 1.7 hours. 
There was an inverted U-shaped association with sleep duration and WF, B-SEVLT sum, and the DSS, with no association with B-SEVLT delayed-recall. 
Participants with intermediate sleep duration had the best neurocognitive function, while long sleepers had worse neurocognitive function adjusting for 
demographic, behavioral, and medical factors, daytime sleepiness, and use of sleep medications.
Conclusions: Sleep duration had curvilinear inverted U-shaped associations with neurocognitive function, with worse scores among participants with longer 
sleep duration. These findings may provide a framework to further examine sleep duration in the prevention and treatment of neurocognitive disorders.
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INTRODUCTION
Longitudinal epidemiological studies demonstrate that short 
(less than 5–6 h) and long (more than 8–9 h) sleep duration is 
associated with increased mortality and stroke.1 Less is known 
about associations between neurocognitive function and sleep 
duration among middle-aged and older adults, especially those 
from diverse ethnic/racial backgrounds. Neurocognitive disor-
ders now represent a major clinical and public health problem 
related to inadequate sleep.2,3 Existing research on sleep du-
ration and neurocognitive function mainly involved older or 
non-Hispanic white cohorts, which limits generalizability to 
middle-aged and non-white populations.4–6
A few studies have observed associations between long 
sleep duration and cognitive function, but these studies are 
mostly from older cohorts that contain relatively small sam-
ples of Hispanic/Latinos and only included measures of global 
cognition such as the mini-mental examination.4–6 In addi-
tion, most studies have not accounted for daytime sleepiness, 
use of sleep medication, and sleep apnea, which are possible 
confounders between sleep duration and neurocognitive func-
tion.7,8 Hispanic/Latinos have a 1.5 increased risk of dementia 
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Significance
Latinos, the largest US ethnic/racial minority, have a 1.5 increased risk of Alzheimer disease and related dementias (ADRD), when compared to Whites. 
We performed a cross-sectional evaluation of sleep duration and neurocognitive function in the Hispanic Community Health Study/Study of Latinos 
(HCHS/SOL), the largest study of Latinos in the U.S. We found curvilinear (inverted U-shaped) associations between sleep duration and neurocognitive 
function. That is, average (7.8 hours ± 1.7 hours) sleep duration was associated with better neurocognitive scores. Our findings confirm that sleep is 
critical for proper neurocognitive function and brain health among diverse, middle-aged and older Latinos. Our findings provide the opportunity to follow 
the HCHS/SOL cohort and better understand midlife sleep with neurocognitive decline and ADRD in future studies.
when compared to non-Hispanic whites,9 but there is a paucity 
of studies evaluating sleep duration and neurocognitive func-
tion in Hispanic/Latino adults.
Previous studies suggest that Hispanic/Latinos may be at 
risk for both short and long sleep durations, but the associa-
tions may differ across different Hispanic/Latino groups.10–15 
For example, in a cross-sectional analysis of NHANES,16 
Mexicans, compared to non-Hispanic whites, had lower odds 
of long sleep, while the “other” Hispanic groups had higher 
odds of very short sleep duration (< 5 h per night). Mexicans 
born in Mexico, compared to US-born, were less likely to re-
port short sleep duration. Recent data from the Hispanic Com-
munity Health Study/Study of Latinos (HCHS/SOL) observed 
significant differences in sleep duration across Hispanics/La-
tinos from four urban areas in the USA.17 In HCHS/SOL, in-
dividuals of Cuban and Mexican backgrounds had the lowest 
prevalence of short sleep duration, while short sleep was most 
prevalent among individuals of Puerto Rican background.17 
Neurocognitive disorders are expected to increase with the 
aging population.2 Therefore, evaluating sleep duration and 
neurocognitive function may provide a critical understanding 
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of how sleep serves as a modifiable risk factor in at-risk 
populations.
Sleep duration has a U-shaped association with adverse 
health outcome7,8,18; therefore, we tested the hypothesis that 
sleep duration has a nonlinear, inverted U-shaped association 
with neurocognitive function, in the largest study of Hispanic/
Latino adults in the U.S.
METHODS
Population
We analyzed data from HCHS/SOL, a multisite, community-
based prospective cohort study. The study’s baseline mea-
surements were collected from 2008 to 2011, and included 
self-identified Hispanic/Latino adults aged 18–74 years 
(n = 16,415), with an oversample (59%) of participants ages 
45–74 years to facilitate examination of target outcomes (e.g., 
cardiovascular mortality).
The HCHS/SOL sampling frame included 4 major U.S. 
cities (Bronx, NY; Chicago, IL; Miami, FL; and San Diego, 
CA) with known substantial Hispanic/Latino concentrations. 
The study used a 2-stage area probability sample design that 
includes clustering, stratification, and probability weighting. 
Detailed description of the HCHS/SOL aims, and study and 
sampling design are published elsewhere.19–21
Protocol and Measurements
The baseline examination included 22 modules designed to 
collect extensive sociodemographic (e.g., economic), behav-
ioral (e.g., diet, sleep), and medical (e.g., medical history, and 
medication use) information on study participants. Question-
naires were administered in Spanish or English based on the 
participant’s language preference. Respondents also under-
went medical assessments, fasting laboratory testing and oral 
glucose tolerance test. The HCHS/SOL was approved by the 
institutional review boards at each field center, and all partici-
pants gave written consent.
Neurocognitive Outcomes
The neurocognitive tests were administered in the participants’ 
preferred language during face-to-face interviews by trained, 
bilingual research assistants. Three neurocognitive tests 
were used in this study: (1) the Brief-Spanish English Verbal 
Learning Test (B-SEVLT),22,23 (2) the Controlled Oral Word 
Association (or Word/Phonemic Fluency; WF) Test of the Mul-
tilingual Aphasia Examination,19 and (3) the Digit Symbol Sub-
test (DSS) of the Wechsler Adult Intelligence Scale-Revised.24
The WF is a test of verbal fluency, the B-SEVLT assesses 
verbal episodic learning and memory function, while the DSS 
is a test of psychomotor speed and working memory.19
The order of B-SEVLT administration was fixed across 3 
learning trials in which participants were asked to recall 15 
common words (List A). After the third trial, a 15-item dis-
tractor list (List B) was introduced in which participants were 
asked to repeat aloud each word. Immediately following the 
interference trial, a delayed free-recall trial for List A occurred.
The WF test has been previously described in detail. Briefly, 
study participants were instructed to orally generate as many 
unique words beginning with a specified letter (F and A) as 
possible within 60 seconds.
The DSS test require participants to rapidly copy symbols 
encoded to numbers (1–9) onto blank spaces below numbers 
printed on scoring sheets within 90 seconds. The outcomes 
were: (1) the summed total number of items correctly recalled 
across the 3 learning trials (B-SEVLT-sum), (2) the memory or 
delayed recall trial (B-SEVLT-recall), (3) the sum of correctly 
generated words beginning with the letters F and A (WF), and 
(4) the total correct score of the DSS. 19
We standardized all neurocognitive scores (i.e. z-score 
transformed) to facilitate interpretation and comparison of 
scores across tests. The neurocognitive assessments were 
chosen based on published validity studies and availability in 
Spanish and English. Detailed description of the HCHS/SOL 
neurocognitive tests are published elsewhere.19
Primary Exposure: Sleep Duration
The following questions were used to determine sleep dura-
tion in our target population: What time do you usually go to 
bed? and What time do you usually wake up? Average sleep 
duration was computed as the weighted average of weekday 
and weekend sleep (5/7 weekday + 2/7 weekend).17 We also 
categorized sleep duration into quartiles based on the HCHS/
SOL target population into 3 groups: short duration (lowest 
quartile), intermediate (interquartile range, [25th to 75th per-
centile] and long sleep duration [highest quartile]). We used 
these cutoffs based on the distribution of sleep duration 
and previous literature on sleep duration and adverse health 
outcomes.17,25
Covariates
We included sex and continuous age (years). We also controlled 
for sociodemographic, health behavior, health conditions, 
mental health indicators, and sleep covariates. Sociodemo-
graphic indicators included education in 3 categories (less 
than high school, high school or equivalent degree, more than 
high school), income (≤ $20,000, $20,001–50,000, ≥ $50,001, 
not reported), occupation (non-skilled, service, professional, 
other), Hispanic background (Cuban, Dominican, Mexican, 
Puerto Rican, Central American, South American), and lan-
guage preference (Spanish, English). Health behavior fac-
tors included a 4-category indicator of body mass index 
(BMI; < 18.5; 18.5 to < 25; 25 to < 30; and 30 +), and self-
reported smoking status (not current smoker; current smoker). 
As previously described, impaired glucose tolerance and dia-
betes mellitus were based on the definition of the American 
Diabetes Association using fasting glucose, oral glucose toler-
ance testing, hemoglobin A1C levels and use of hypoglycemic 
medications. Hypertension was defined as a systolic blood 
pressure (BP) ≥ 140 and/or diastolic BP ≥ 90 mm Hg, respec-
tively, or antihypertensive medication use. The analyses also 
controlled for depressive symptoms score (Center for Epide-
miological Studies Depression Scale; CES-D10), anxiety score 
(State-Trait Anxiety Inventory-10-item),26,27 and self-reported 
prevalent stroke/TIA. Finally, given the HCHS/SOL multi-
center design, the final models also controlled for potential 
field center effects.
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Sleep Covariates
Sleep history and symptoms were assessed using items from 
the Sleep Heart Health Study Sleep Habits Questionnaire and 
the Epworth Sleepiness Scale (ESS).17,28,29 The sleep habits 
questionnaire ascertained symptoms of snoring, breathing 
pauses in sleep, insomnia, and restless legs symptoms. We 
also accounted for self-reported use of sleep medications with 
responses ranging from no-use per week to use more than 5 
days per week.
Study Subpopulation
The focus of this study was on respondents’ ages 45–74 years 
agreeing to participate in the neurocognitive module of HCHS-
SOL (n = 9,623). We excluded 227 participants who did not 
report a specific Latino background (n = 9,396). Furthermore, 
we only included participants with complete data on the model 
covariates and the sleep duration variable. Among respondents 
satisfying criteria for inclusion, 4.7% had missing values on 
our model covariates (n = 8,950), and an additional 3.1% had 
missing values on sleep duration (n = 8,676). A detailed ac-
counting of the sample exclusion criteria and missingness pat-
terns is included in the supplemental material (Table S1). To 
ensure that the impact of missing covariates does not bias our 
reported results, we conducted bivariate sensitivity analyses 
to compare the association between sleep duration and neuro-
cognitive scores in (1) the sample of participants not excluding 
respondents with missing values on the covariates and (2) the 
subsample of respondents excluding those with incomplete 
covariate data. This sensitivity check revealed that the re-
sults were largely qualitatively unchanged—an indication of 
the robustness of our reported findings. Respondents with in-
complete data on sleep duration were slightly more likely to 
be male, Puerto Rican, and to originate from the Chicago and 
Miami sites of the study. Respondents with missing sleep du-
ration values were also more likely to be smokers, more likely 
to self-report a stroke/TIA, and to have slightly higher av-
erage anxiety scores. To accommodate HCHS/SOL’s complex 
sample design, all analyses were performed using survey pro-
cedures that account for clustering, stratification, and unequal 
probability weighting in the Stata software package version 
13.1. Methods appropriate for the analyses of subpopulations 
were applied to generate our parameters’ estimates. We used a 
Taylor Series Linearization approach to variance estimation to 
obtain sample design adjusted standard errors.
Analytic Approach
First, we generated descriptive statistics to characterize 
the overall study population and by sleep duration intervals. 
Second, we fit linear survey regression models to test the re-
lationships between sleep duration and its quadratic order 
(squared sleep duration) and each of the 4 neurocognitive tests. 
We fit 3 models for each neurocognitive test. In the first model 
(unadjusted) we tested the curvilinear (inverted U-shaped) as-
sociation between sleep duration and neurocognitive scores. 
We also considered other functional forms including higher 
order polynomials (e.g., cubic). The second model adjusted 
the baseline model to account for age, sex, and education. The 
third model further adjusted for sociodemographic, health 
behavior, health conditions, and sleep covariates. In additional 
models, we examined the interactions for several pre-specified 
sets of analyses; i.e., between sleep duration and sex and sleep 
duration and age groups (45–54; 55–64; 65–74), to test for dif-
ferential effects of age and sex on neurocognitive function. We 
also used U-shaped specific tests to verify both the appropri-
ateness of the second derivative and the range of the inflec-
tion point data.30 To facilitate the interpretation of our results, 
we calculated and plotted the adjusted average neurocognitive 
scores and their 95% confidence bounds over the range of re-
ported sleep duration.
Sensitivity Analyses
We repeated the primary analysis, excluding participants with 
self-reported histories of stroke and transient ischemic at-
tacks using all modeling steps detailed above. The findings 
from these analyses (reported in Table S3 and Figure S1 in the 
supplemental material) indicated that our reported results and 
conclusions were robust to this sample re-specification. Addi-
tionally, we considered a categorical operationalization of sleep 
duration using 5 percentile groupings (1 = < 5th; 2 = 5th to < 25th; 
3 = 25th to < 75th; 4 = 75th to < 95th; and 5 = 95th +). Analyses 
were repeated in accordance with the steps detailed above. The 
result of these analyses are described below and presented in 
Table S4 in the supplemental material. Additionally, the es-
timated marginal effects and their 95% confidence intervals 
are plotted in Figure S2 in the supplemental material to fa-
cilitate interpretation. Overall the findings pointed to similar 
curvilinear associations between sleep duration and cognitive 
scores with lower scores particularly apparent at higher sleep 
duration centiles (> 75th percent).
RESULTS
Weighted descriptive statistics for the overall target population 
and for the three sleep duration groups are presented in Table 1. 
The overall range of self-reported sleep duration was between 
3 and 13.5 h (IQR = 7–8.7 h). The average sleep duration was 
7.85 h (SD 1.73 h). The mean age was 57 years, and more than 
half were females. Mexican background was the largest His-
panic/Latino group represented in our target population, fol-
lowed by Cuban and Puerto Rican backgrounds. Forty percent 
had less than high school education (40.4%), nearly half (46%) 
had a household income ≤ $20,000, and close to three-fifths 
had a service or non-skilled occupation. Spanish was the lan-
guage of preference (86%).
Compared to those with sleep duration within the IQR 
(7–8.7 h), those in the lowest (< 7 h; short sleep) and highest 
sleep quartiles (> 8.7 h; long sleep) were more likely to have 
lower education, lower incomes and to use English as their 
preferred language. Those with long sleep durations had an 
increased prevalence of diabetes mellitus and hypertension. 
Those with short sleep had increased prevalence of obesity and 
higher sleepiness scores; while those with long sleep reported 
using more sleep medications.
The regression analyses demonstrated (Table 2) a curvi-
linear (inverted U-shaped) association between sleep du-
ration and neurocognitive function evidenced across all 4 
cognitive tests.
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Table 1—Weighted sociodemographic, behavioral and health characteristics of middle-aged and older (45 to 74 years) Hispanics/Latino adults, 
HCHS/SOL 2008–2011 (n = 8,676).
Overall < 25th Percentile(< 7 h)
25th–75th Percentile
(7–8.71 h)
> 75th Percentile
(> 8.71 h) Test
Sex, female, % 55.0 52.7 53.5 60.4 P = 0.0011
Education, % P = 0.0048
Less than HS 40.4 41.6 37.8 44.9
HS or Equivalent 21.3 19.7 22.2 20.5
More than HS 38.4 38.7 40.0 34.6
Latino Background, % P < 0.001
Dominican 9.5 11.2 8.8 9.3
Central American 6.9 7.0 7.5 5.5
Cuban 27.7 25.1 27.8 29.8
Mexican 32.2 25.6 34.7 32.7
Puerto Rican 18.2 25.2 15.4 18.2
South American 5.5 5.9 5.8 4.6
Language, English, % 13.8 18.4 12.0 13.7 P = 0.0006
Center, % P < 0.001
Bronx 26.0 34.7 22.9 25.3
Chicago 12.9 12.7 13.0 12.8
Miami 36.3 32.9 37.5 36.5
San Diego 24.9 19.8 26.6 25.4
Income, % P < 0.001
≤ $20,000 45.9 46.0 42.5 53.4
$20,001–50,000 33.8 35.0 36.5 26.8
≥ $50,001 10.8 11.2 11.7 8.3
Not Reported 9.6 7.9 9.3 11.5
BMI, % P = 0.0222
Underweight 0.5 0.4 0.6 0.5
Normal 16.1 14.4 16.7 16.4
Overweight 41.1 37.3 42.5 41.5
Obese 42.3 47.9 40.3 41.6
Occupation, % P < 0.001
Non-skilled worker 19.9 17.9 18.0 25.9
Service worker 36.6 32.6 34.4 44.9
Professional 13.5 13.6 14.4 11.5
Other 29.9 35.8 33.2 17.7
Diabetes, % P < 0.001
Not Diabetic 24.8 23.4 26.1 23.3
Pre Diabetic 45.3 46.9 46.8 40.9
Diabetic 29.8 29.7 27.1 35.9
Hypertension, hypertensive, % 48.4 48.3 46.3 53.0 P = 0.0032
Smoking, current smoker, % 20.2 22.3 19.7 19.4 P = 0.2015
Stroke/TIA, yes, % 4.0 4.4 3.3 5.2 P = 0.0463
Sleeping Medication, % P < 0.001
Not, in the past four weeks 82.0 82.3 84.3 76.6
Yes, less than once a week 2.9 3.7 2.7 2.7
Yes, 1 or 2 times a week 3.6 2.9 3.6 4.3
Yes, 3 or 4 times a week 2.7 4.1 2.1 2.9
Yes, 5 or more time a week 8.8 7.0 7.3 13.6
Age, years, mean 56.5 55.9 56.3 57.6 P < 0.001
CES-D10 score, mean 7.5 8.2 6.8 8.4 P < 0.001
STAI-Trait score, mean 17.0 17.4 16.5 17.6 P < 0.001
ESS score, mean 5.9 6.9 5.8 5.3 P < 0.001
Reported P values are based on survey adjusted chi-squared tests for categorical variables, and t-tests for continuous variables. CES-D10, Center for 
Epidemiological Studies – Depression 10 item scale; STAI-Trait, Spielberger State-Trait Anxiety Inventory 10 item trait scale; ESS, Epworth Sleepiness 
Scale, BMI, body mass index.
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These associations remained after adjusting for age, sex, and 
education. With the exception of the B-SEVLT-Recall test (de-
layed memory), the quadratic term of sleep duration and neu-
rocognitive function remained significant after adjustments 
for sociodemographic, health behavior, medical conditions, 
sleepiness, and sleep medication covariates. The inflection 
points for sleep duration in relation to neurocognitive scores 
that were derived from the adjusted models were B-SEVLT-
Sum (6.8 h; SE = 0.7), B-SEVLT-Recall (5.3 h; SE = 3.2), WF 
(6.6 h; SE = 0.8), and DSS (5.7 h; SE = 0.9). Table 3 includes 
the estimated inflection points for the U-shaped curves, for all 
tests and models, and their SE and 95% CIs. Figure 1 plots the 
estimated average covariate-adjusted cognitive scores over the 
sleep duration continuum and their 95% confidence bounds.
After full adjustment for our covariates, participants with 
shorter sleep durations had similar neurocognitive scores than 
participants with intermediate sleep durations, while partici-
pants with longer sleep duration had worse neurocognitive 
scores across all tests (Figure 1, Figure S2 in the supplemental 
material). Incremental models were constructed to determine 
the role of our model covariates in explaining the curvilinear 
association between sleep duration and B-SEVLT-recall 
(verbal memory). We fit 5 additional models that sequentially 
controlled for sociodemographic, mental health, self-reported 
medical conditions, health behavior factors, sleepiness, and 
sleep medication covariates. The statistical association be-
tween sleep duration and B-SEVLT-recall was largely ex-
plained by the sociodemographic controls including Hispanic/
Latino background group, language, income, employment, and 
study center. These results are presented in Table S2 in the 
supplemental material.
We observed an interaction between sleep duration and sex. 
Stratified analysis indicated that the association between sleep 
duration and neurocognitive function differed between males 
Table 3—Inflection point estimates and their 95% confidence intervals 
for sleep duration (h) and neurocognitive in middle-aged and older (45 
to 74) Hispanics/Latino adults, HCHS/SOL 2008–2011.
Inflection Point SE 95% CI
SEVLT Sum Model 1 7.2 0.2 6.7, 7.7
Model 2 7.3 0.2 6.8, 7.8
Model 3 6.8 0.7 5.5, 8.2
SEVLT Recall Model 1 7.2 0.3 6.6, 7.7
Model 2 7.3 0.3 6.8, 7.9
Model 3 5.3 3.2 −0.9, 11.5
WF Model 1 7.1 0.3 6.5, 7.7
Model 2 7.2 0.4 6.4, 7.9
Model 3 6.6 0.8 5.0, 8.3
DSS Model 1 6.5 0.3 5.9, 7.1
Model 2 6.5 0.5 5.6, 7.4
Model 3 5.7 0.9 4.0, 7.4
Results are based on survey linear regression models using data 
from the Hispanic Community Health Study/Study of Latinos. Model 
1 unadjusted; Model 2 adjusted for age, sex and education; Model 
3 adjusted for all model covariates (age, sex, education, income, 
occupation, Latino background, language preference, study site, BMI, 
smoker status, diabetes, hypertension, stroke/transient ischemic attack, 
depressive symptoms using the shortened Center for Epidemiological 
Studies Depression Scale, anxiety using the 10-item State-Trait 
Anxiety Inventory summary score, Epworth Sleepiness Scale, and 
sleep medication). Quadratic Term = Second order polynomial of 
sleep duration. B-SEVLT, Brief–Spanish English Verbal Learning Test; 
DSS, Digit Symbol Substitution test of the Wechsler Adult Intelligence 
Scale–Revised; WF, Word/phonemic Fluency or Controlled Oral Word 
Association Test of the Multilingual Aphasia Examination.
Table 2—Association between sleep duration and neurocognitive function in middle-aged and older (45 to 74 years) Hispanics/Latino adults, HCHS/SOL 
2008–2011.
Model 1 Model 2 Model 3
beta-coefficient
(standard error) Wald Test
Inverted 
U-Shape Test
beta-coefficient
(standard error) Wald Test
Inverted 
U-Shape Test
beta-coefficient
(standard error) Wald Test
Inverted 
U-Shape Test
SEVLT sum (n = 8,624)
P < 0.0001 P < 0.0001 P < 0.0001 P < 0.0001 P < 0.01 P = 0.0374
Sleep duration
Linear   0.299 (0.057)***   0.240 (0.051)*** 0.100 (0.05)*
Quadratic −0.021 (0.004)*** −0.016 (0.003)*** −0.007 (0.003)*
SEVLT recall (n = 8,622)
P < 0.0001 P < 0.0001 P < 0.0001 P < 0.0001 P = 0.0642 P = 0.344
Sleep duration
Linear   0.250 (0.058)***   0.205 (0.054)***   0.032 (0.055)
Quadratic −0.017 (0.004)*** −0.014 (0.003)*** −0.003 (0.003)
WF (n = 8,512)
P < 0.0001 P < 0.0001 P < 0.0001 P < 0.0001 P = 0.0117 P = 0.0704
Sleep duration
Linear   0.294 (0.067)***   0.230 (0.066)*** 0.116 (0.068)
Quadratic −0.021 (0.004)*** −0.016 (0.004)*** −0.009 (0.004)*
DSS (n = 8,436)
P < 0.0001 P < 0.0001 P < 0.0001 P < 0.01 P < 0.0001 P = 0.0585
Sleep duration
Linear   0.261 (0.055)***   0.166 (0.047)***  0.080 (0.038)*
Quadratic −0.020 (0.003)*** −0.013 (0.003)*** −0.007 (0.002)**
*P < 0.05; **P < 0.01; ***P < 0.001.  Results are based on survey linear regression models using data from the Hispanic Community Health Study/Study of Latinos. Model 1 unadjusted; Model 2 
adjusted for age, sex and education; Model 3 adjusted for all model covariates (age, sex, education, income, occupation, Latino background, language preference, study site, BMI, smoker status, 
diabetes, hypertension, stroke/transient ischemic attack, depressive symptoms using the shortened Center for Epidemiological Studies Depression Scale, anxiety using the 10-item State-Trait Anxiety 
Inventory summary score, Epworth Sleepiness Scale, and sleep medication). Quadratic Term is second order polynomial of sleep duration. B-SEVLT, Brief–Spanish English Verbal Learning Test; 
DSS, Digit Symbol Substitution test of the Wechsler Adult Intelligence Scale–Revised; WF, Word/phonemic Fluency or Controlled Oral Word Association Test of the Multilingual Aphasia Examination.
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and females (Figure 2). The stratified analyses showed a cur-
vilinear association between sleep duration and SEVLT sum 
among women (P = 0.026) but not men (P = 0.187). As with the 
overall analyses, we found that in fully adjusted models the 
association between sleep duration and SEVLT recall was not 
significant, explained through controlling for our model covari-
ates, for both women and men. Finally, we found curvilinear 
associations between sleep duration and both the word fluency 
and the digit symbol substitution tests among men (P = 0.0113) 
but not among women (P = 0.005) (Figure 2). Finally, we found 
no consistent interaction effects between age and sleep dura-
tion with neurocognitive function (data not shown). Analyses 
of the subsample of participants without reported stroke/TIA 
(reported in Table S3 and Figure S1 in the supplemental ma-
terial) were quantitatively and qualitatively similar to the 
overall sample, suggesting that our reported results and con-
clusions were robust to this sample re-specification. Finally, in 
Table S4 in the supplemental material, we present the results 
of the survey linear regression models testing the association 
between the percentiles of sleep duration and our neurocogni-
tive tests of interest. Figure S2 in the supplemental material 
shows the estimates and their 95% confidence intervals de-
rived from survey linear regression models across percentiles 
of sleep duration. The 5th percentile was ≤ 5.5 h of sleep; the 
5th to < 25th percentile was from 5.51 to 7.0 h; the 25th to < 75th 
percentile was from 7.1 to 8.7 h; the 75th to < 95th percentile was 
from 8.8 to 10.1 h; and the 95th percentile was > 10.1 h of re-
ported sleep duration. Overall these findings pointed to similar 
curvilinear associations between sleep duration and cognitive 
scores with lower NC scores particularly apparent at higher 
durations of sleep (> 75th percentile).
DISCUSSION
In this large cohort of middle-aged and older Hispanic/Latino 
adults, the highest neurocognitive performances were observed 
among participants with intermediate sleep duration.31,32 In our 
study, the associations between neurocognitive function and 
sleep duration formed a consistent inverted U-shaped function 
across neurocognitive tests. The observed associations were 
not explained by the covariates considered in our study, with 
the exception of delayed memory, which was explained by so-
ciodemographic factors.
Shorter sleep duration has been associated with increased 
deposition of brain amyloid33 and poor neurocognitive func-
tion34; however, the association was weak to null in our sample. 
Conversely, studies in young to middle-aged adults have 
shown associations between short sleep and worse executive 
function, working memory and attention.25 In contrast, HCHS/
SOL participants with longer sleep durations had markedly 
lower neurocognitive scores, consistent with evidence from 
cross-sectional and longitudinal studies suggesting that long 
sleep predicts impaired neurocognitive function and dementia 
in older adults.4,6–8
In our study, the association between sleep duration and 
neurocognitive function was seen across all cognitive tests, ex-
cept for delayed memory. In a cohort of older men, disturbed 
sleep was associated primarily with decline in executive func-
tion, but not with global cognition.4 Similarly, the Whitehall II 
study described worse cognitive function (except for memory), 
in participants who changed their sleep duration, from average 
to short or average to long sleep, after 5 years of follow-up.35
The observed associations between sleep duration and 
neurocognitive function were seen in middle-aged and older 
adults across different neurocognitive tests. These contrast to 
other studies where self-reported sleep was evaluated in older 
adults with measures of global cognition (i.e., mini-mental 
score), which may be insensitive to cognitive variability.2,6
We observed an interaction between sleep duration and sex. 
Stratified analysis indicated that the association between sleep 
duration and cognitive function differed between males and 
Figure 1—Standardized neurocognitive score adjusted-mean by sleep duration of middle-aged and older (45 to 74 years) Hispanics/Latino adults, HCHS/
SOL 2008–2011. Estimates and their 95% confidence bounds are derived from survey linear regression models using data from the Hispanic Community 
Health Study/Study of Latinos. The models were adjusted for age, sex, education, income, occupation, Latino background, language preference, study 
site, BMI, smoker status, diabetes, hypertension, stroke/transient ischemic attack, depressive symptoms using the shortened Center for Epidemiological 
Studies Depression Scale, anxiety using the 10-item State-Trait Anxiety Inventory summary score, Epworth sleepiness scale, and sleep medication. The 
x-axis is the weighted average for weekday and weekend sleep duration in hours. The y-axis represents standardized neurocognitive test score in units of 
standard deviation. B-SEVLT, Brief–Spanish English Verbal Learning Test; DSS, Digit Symbol Substitution test of the Wechsler Adult Intelligence Scale–
Revised; WF, Word/phonemic Fluency or Controlled Oral Word Association Test of the Multilingual Aphasia Examination. 
SLEEP, Vol. 39, No. 10, 2016 1849 Sleep Duration and Neurocognitive Function—Ramos et al.
females. Other studies have identified sex differences in sleep 
duration and neurocognitive function such that females with 
long sleep (> 9 h per night) had cognitive impairment at one 
year of follow-up; while short sleep (< 5 h per night) predicted 
cognitive decline in males.36 Our findings suggest that sleep 
duration may differentially affect neurocognitive function in 
men and women.
There is a paucity of studies examining a mechanism by 
which long sleep may cause adverse health consequences or 
neurocognitive dysfunction.37 Some research suggests that 
sleep fragmentation may be the critical determinant of neu-
rocognitive function in sleep and aging.25 Long sleep dura-
tion is also associated with cerebrovascular disease, increased 
brain white-matter hyperintensities and stroke; factors linked 
to worse neurocognitive outcomes.38–40 It is plausible that 
cerebrovascular damage associated with long sleep, affects 
white matter tracts and inter-connections between cortical 
areas and subcortical structures, resulting in neurocognitive 
dysfunction.41,42
This work represents an important advance in understanding 
sleep duration and neurocognitive function in a representative 
sample of middle-aged and older Hispanic/Latino adults from 
diverse backgrounds. The strengths of our study are the use of 
a large, diverse sample of Hispanic/Latino backgrounds, with 
multiple neurocognitive tests, strict quality-control procedures 
and use of standardized measurements and central scoring for 
both neurocognitive tests and sleep measures.
The limitations of this study include the use of self-reported 
sleep duration. In our study, the questions used for sleep dura-
tion may reflect time in bed, rather than sleep duration and we 
may have overestimated sleep by including sleep onset latency 
and wake after sleep onset.17
Figure 2—Sex differences in estimated average standardized neurocognitive scores over sleep duration in middle-aged and older (45 to 74 years) 
Hispanics/Latino adults, HCHS/SOL 2008–2011. Average NC score estimates and their 95% confidence bounds and sleep duration (linear and quadratic) 
stratified by sex in survey linear regression models using data from the Hispanic Community Health Study/Study of Latinos. The models were adjusted 
for age, education, income, occupation, Latino background, language preference, study site, BMI, smoker status, diabetes, hypertension, stroke/transient 
ischemic attack, depressive symptoms using the shortened Center for Epidemiological Studies Depression Scale, anxiety using the 10-item State-Trait 
Anxiety Inventory summary score, Epworth sleepiness scale, and sleep medication. The x-axis is the weighted average for weekday and weekend sleep 
duration in hours. The y-axis represents standardized neurocognitive test score in units of standard deviation. The P values reported in the graphs are 
based on survey adjusted Wald-tests that the linear and quadratic coefficients for sleep duration are jointly equal to zero. For the DSS, among females, 
only the linear term (P < 0.001) reached statistical significance. B-SEVLT, Brief–Spanish English Verbal Learning Test; DSS, Digit Symbol Substitution 
test of the Wechsler Adult Intelligence Scale–Revised; WF, Word/phonemic Fluency or Controlled Oral Word Association Test of the Multilingual Aphasia 
Examination.
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Different from previous studies,7,8 we controlled for impor-
tant sleep confounders such as daytime sleepiness, use of sleep 
medications and excluded participants with sleep apnea by 
home sleep testing. However, we did not adjust for shift-work, 
daytime napping, and number of household members. In ad-
dition, we did not assess the participant’s sleep schedules over 
time, which could have been informative. The cross-sectional 
nature of the analysis does not allow inference of causality. We 
cannot exclude possible influences of reverse causality due to 
preexisting disease or other confounders. As such these asso-
ciations require future considerations.
Additionally, language, a surrogate for acculturation, did 
not change the associations between sleep duration and neu-
rocognitive function in our sample. However, further investi-
gations of acculturation measures (nativity, years of residence, 
and language preference) as modifiers of the relationship 
between sleep duration and neurocognitive performance are 
necessary. We did not define cases of cognitive impairment or 
dementia; however, given the cohort’s younger mean age (57 
years), dementia cases would likely be few. As this cohort ages, 
our findings provide an opportunity to longitudinally evaluate 
and act upon the factors associated with sleep-related neuro-
cognitive dysfunction and brain health in midlife and older 
Hispanics/Latinos.19
In summary, we found that intermediate sleep duration was 
associated with higher neurocognitive function in the largest 
study of middle-aged and older Hispanics/Latinos of diverse 
backgrounds to date. We observed curvilinear inverted U-
shaped associations between sleep duration and neurocog-
nitive function, with worse scores among participants with 
longer sleep durations. Our findings may provide a framework 
by which sleep and neurocognitive dysfunction could be exam-
ined in longitudinally and treatment studies for the prevention 
of neurocognitive disorders.
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